Klotho Neurosciences, Inc. Cash Flow-to-Debt Ratio
Klotho Neurosciences, Inc. cash flow-to-debt ratio. Klotho Neurosciences, Inc. (KLTO) has a Cash Flow-to-Debt Ratio of -7.46x as of September 2025, meaning its operating cash flow of $-1.09 Million could theoretically repay -7% of its total liabilities ($145.89K) in one year. See Klotho Neurosciences, Inc. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Klotho Neurosciences, Inc. (2021–2024)
Cash flow-to-debt ratio of Klotho Neurosciences, Inc. from 2021 to 2024. Historical debt coverage capacity for Klotho Neurosciences, Inc. across 4 annual periods. Check Klotho Neurosciences, Inc. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Klotho Neurosciences, Inc. Cash Flow-to-Debt Ratio by Year (2021–2024)
Klotho Neurosciences, Inc. cash flow-to-debt ratio by year from 2021 to 2024. Year-by-year debt coverage analysis for Klotho Neurosciences, Inc.. For the full cash flow conversion analysis, see KLTO cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.32x | $-2.95 Million | $1.27 Million | ▼ -740.2% |
| 2023 | -0.28x | $-446.92K | $1.62 Million | ▲ +37.4% |
| 2022 | -0.44x | $-599.57K | $1.36 Million | ▲ +97.7% |
| 2021 | -18.77x | $-284.02K | $15.13K | — |